Emergo Group

What Emergo Group does

Emergo Group, operating as Emergo by UL, is a global medical device regulatory affairs and human factors engineering consulting firm founded in 1997 and headquartered in Austin, Texas. The firm now operates as a subsidiary of UL Solutions, delivering services from more than 20 offices across six continents and serving over 2,000 medical device and in-vitro diagnostic (IVD) manufacturers worldwide. Its core offerings span market access consulting for major regulatory jurisdictions (EU MDR/IVDR, US FDA, Japan PMDA, Brazil ANVISA, and other markets), human factors research and design services (user research, usability testing, use-related risk analysis, validation), and in-country representation services such as Brazil Registration Holder (BRH) and Japan MAH/DMAH acting for foreign manufacturers.

The firm has layered proprietary software on top of its consulting base. RAMS (Regulatory Affairs Management Suite) is a platform of digital products covering product classification, document building, registration tracking, regulatory watch, regulatory intelligence, and reporting, with e-learning modules. OPUS (Optimal Product Usability Suite) is a cloud-based human factors engineering platform providing training, tools, templates, and document libraries. Both are supported by extensive content marketing — including the RADAR and TalkingPoints newsletters and dedicated resource centers for MDR, IVDR, LATAM, and Asia — that functions as a top-of-funnel acquisition engine.

Revenue is generated through three streams: professional services for regulatory and human factors consulting (quote-based, multi-year contracts), subscription-based access to RAMS and OPUS software, and recurring in-country representation fees for foreign manufacturers operating in Brazil and Japan. Go-to-market is primarily enterprise field sales supplemented by self-serve PLG channels for the software platforms. Leadership includes Vice President of Regulatory & Clinical Affairs Jaap Laufer and General Manager of the Human Factors Engineering Practice Michael Wiklund, alongside a global bench of certified human factors professionals, regulatory specialists, and engineers.

Name

Emergo Group

Legal name

Emergo Global Consulting LLC

Website

https://emergobyul.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Emergo by UL is a global medical device regulatory affairs and human factors engineering consulting firm serving 2,000+ device and IVD manufacturers across 20+ offices on six continents, combining market access consulting with RAMS and OPUS software platforms.

Ownership category

akta.pro rank

Product category

Medical Device Regulatory Consulting

NAICS

Management Consulting Services (54161), Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industries

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO), Inspection Readiness & Regulatory Authority Support (FDA/EMA/MHRA) (HLAGAKAF)

Keywords

• Medical device regulatory consulting
• Human factors engineering
• Regulatory affairs software
• EU MDR IVDR compliance
• In-country regulatory representation

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Regulatory Consulting Services: Professional consulting services for medical device regulatory compliance including market access, device registration, quality management systems, and post-market surveillance across global markets including EU MDR, IVDR, Japan, Brazil, US FDA, and other regulatory jurisdictions.
2. Human Factors Engineering Services: Consulting services for human factors research, design, usability testing, and regulatory compliance including formative and HF validation testing, expert critiques, heuristic analyses, cognitive walkthroughs, and user research.
3. Software Subscriptions (RAMS and OPUS): Subscription-based digital platforms providing regulatory affairs management tools and human factors engineering tools, training, templates, and resources.
4. In-Country Representation Services: Brazil Registration Holder (BRH) services acting as authorized representative for foreign manufacturers in Brazil; similar services for Japan and other markets.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Emergo by UL provides professional regulatory affairs consulting and human factors engineering services to medical device and IVD manufacturers seeking global market access, complemented by two proprietary software platforms—RAMS® for RA/QA workflow automation and OPUS™ for human factors engineering. The firm additionally serves as an in-country regulatory representative (e.g., Brazil Registration Holder) for foreign manufacturers seeking entry into regulated markets including the EU, US, Japan, and Brazil.

Product overview

Emergo by UL offers a dual-pronged approach combining consulting services with proprietary software platforms. The core software products are RAMS® (Regulatory Affairs Management Suite) — a platform of digital products for RA/QA activities covering EU MDD, MDR, and IVDR compliance — and OPUS™ (Optimal Product Usability Suite) — a human factors engineering platform providing training, tools, templates and regulatory guidance. RAMS® modules include Product Classification, Smart Builder, e-Learning, Registration Tracker, Regulatory Watch, Regulatory Intelligence, and Regulatory Reports. OPUS™ modules include Subscriptions, eLearning, Documents, and Tools. The company also provides consulting services including market access, human factors research and design, training, and privacy/security services, complemented by regional resource centers for MDR, IVDR, LATAM, and Asia. Two newsletters — RADAR for market access and TalkingPoints for human factors — round out the offering.

Differentiator

Problem solved

Functional benefit

Brands

• RAMS (Regulatory Affairs Management Suite): A platform of digital products to improve, simplify and automate RA/QA activities for medical device compliance.
• OPUS (Optimal Product Usability Suite)

Products and services

• Market Access Consulting Global regulatory compliance consulting service that helps medical device and IVD manufacturers achieve and maintain market access worldwide, covering EU MDR/IVDR, US FDA, Japan PMDA, Brazil ANVISA, and other jurisdictions.
• Human Factors Research & Design Consulting service applying human factors engineering throughout the medical device product development lifecycle, including user research, usability testing, use-related risk analysis, and design optimization for medical devices and IVDs.
• Human Factors Analysis Services Comprehensive human factors analysis service including use-related risk analysis, task analysis, hazard analysis, anthropometric analysis, and known-problems analysis for medical device development.
• Early Stage Design Consulting Expert consulting for medical device development during the discovery phase, including research, human factors, design exploration, and regulatory pathway strategy.
• Human Factors Training & Consulting Expert HFE training, consulting, and regulatory strategy support, including customized workshops, webinars, and in-house program development for medical device and combination product companies.
• Privacy & Security Services Privacy and security consulting services for medical device and IVD companies, covering data protection and cybersecurity compliance requirements for regulated medical products.
• RAMS (Regulatory Affairs Management Suite) Subscription-based digital platform to improve, simplify, and automate RA/QA activities for global medical device registration and compliance management, offering services for EU MDD, MDR, and IVDR.
• OPUS (Optimal Product Usability Suite) Cloud-based human factors engineering software platform providing training, tools, templates, and regulatory guidance to help users execute HFE activities for medical devices, IVDs, and combination products.
• In-Country Representation Services Regulatory representation services where Emergo by UL acts as Brazil Registration Holder (BRH) and Japan MAH/DMAH for foreign manufacturers, serving as official liaison with ANVISA, PMDA, and other in-country authorities. Emergo by UL is the official in-country regulatory representative for more than 2,000 medical device and IVD companies worldwide.

Quantifiable outcome

• Emergo has experience with successful AREE submissions to ANVISA that minimize the chance of receiving additional questions about performance testing and clinical data
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ANVISA (Brazil National Health Surveillance Agency)coreOthersEmergo by UL serves as Brazil Registration Holder (BRH) acting as official liaison between foreign manufacturers and ANVISA. This is a regulatory representation relationship where Emergo interacts with ANVISA on behalf of clients for device registration, B-GMP quality system inspections, and compliance matters.

Scale indicators2 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• TÜV SÜD: TÜV SÜD operates a Notified Body for medical devices and offers a wide range of regulatory and HFE advisory services, often overlapping with Emergo's client base. A broad incumbent in conformity assessment that competes with both the consulting and certification sides of Emergo/UL.
• BSI Group: BSI is a major Notified Body and offers regulatory advisory, ISO 13485 certification, and MedTech market access services. Comparable to Emergo as an established, full-service medical device regulatory and certification provider, though BSI's portfolio extends well beyond consulting.
• ICON plc: ICON is a global CRO with significant regulatory affairs and clinical services serving medical device and pharma clients. Comparable to Emergo at the high end of regulatory consulting, though much broader in scope and primarily pharma-weighted.
• NSF: NSF provides medical device regulatory consulting, testing, and certification services globally, including ISO 13485 and CE marking support. Comparable as a broad-scope safety science and regulatory consultancy serving medical device manufacturers, though NSF's portfolio spans far beyond MedTech.
• IQVIA: IQVIA is a large CRO and healthcare data/regulatory services provider with regulatory affairs offerings serving MedTech and pharma. Comparable as a global regulatory and clinical consulting incumbent, though MedTech is a smaller share of its business than for Emergo.
• DEKRA: DEKRA provides medical device testing, certification, and regulatory advisory globally, including Notified Body services. Overlaps with Emergo on regulatory consulting and certification for device manufacturers seeking market access in Europe.

Direct peers

• Qserve Group: Qserve is a medical device regulatory and HFE consultancy with strong European presence, including Notified Body expertise. Directly competes with Emergo on EU MDR/IVDR consulting and usability engineering services for device manufacturers.
• NAMSA: NAMSA is a medical device-focused contract research organization (CRO) offering regulatory, quality, clinical, and testing services. Directly comparable to Emergo on the regulatory affairs side, with similar concentration on MedTech OEMs seeking global market access.
• Maetrics: Maetrics specializes in medical device and IVD regulatory compliance, quality systems, and HFE consulting. Comparable as a focused consultancy addressing the same regulatory pain points (MDR, IVDR, FDA, ISO 13485) that Emergo serves, though smaller and less globally distributed.
• Veranex (formerly RQM+): Veranex acquired RQM+ in 2024 to form a global MedTech solutions platform combining regulatory affairs, quality, clinical research, and HFE consulting. Directly comparable to Emergo in medical device regulatory and HFE services across US, EU, and Asia, with overlapping customer base of device manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/TheEmergoGroup
• LinkedInlinkedin.com/company/emergobyul
• Xx.com/EmergoGroup
• Facebookfacebook.com/emergobyul

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emergo Group